Abstract
The rapidly developing field of cancer treatment requires versatile strategies for controlled drug delivery and diagnostics. Molecular imaging technology has gained attraction in cancer diagnosis and therapy, partially driven by nanoparticle-based theranostic agents. Nanotheranostics-based imaging platforms offer insights into both malignancy diagnosis and therapeutic response monitoring. Monitoring body response to certain cancer treatment will offer suitable pathological and surgical evaluation guides to evaluate how tumors shrink/metastasize, as well as the side effects associated with the therapeutic approach. This chapter summarizes fundamental imaging features of nanotheranostics, specifically, treatment monitoring in cancer therapy, with applications in therapeutic monitoring, such as tracking angiogenesis, metastasis, and apoptosis, following primary treatment. This chapter also offers an outlook for future translation and clinical applications of such multifunctional nanoconstructs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have